versión imprimible
 
 

Integrin-Targeted Drug Discovery Summit | Virtual | August 17-19

Evvnt Promotion / evvnt
-
17.08.2021 - 19.08.2021  Virtual
Time: 9:00 am - 5:00 pm
 
Temas de la conferencia
Invigorate Your Pipeline and Drive Translational Development as the Field of Integrins Explodes

The excitement surrounding integrins has been growing over the past few years, culminating in recent clinical success, innovative biology and medicinal chemistry advancements blazing the way to tackle previously undruggable disease modalities through novel integrin targets
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Dean Sheppard, Chief of Pulmonary, Critical Care, Allergy and Sleep and Director of Lung Biology Center, University of California, San Francisco, Katerina Leftheris, Vice President and Head of Chemistry, Pliant Therapeutics and more
 

Información e inscripción:

https://go.evvnt.com/781967-1?pid=4832
Ms. Caroline Hunt
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Drug Developer Conference Only-Early birds available: USD 1499.00, Drug Developer Full Access-Early birds available: USD 2096.00, Academic Conference Only-Early birds available: USD 1199.00, Academic Full Access-Early birds available: USD 1646.00
Los participantes esperaban
100
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

European Health Forum GasteinÖsterreichisches Rotes KreuzEuropean Public Health Association (EUPHA)OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AMREF - African Medical and Research FoundationÖsterreichische Gesellschaft für Public HealthÄrzte der WeltÖsterreichische Akademie der Ärzte